Holdings of T. Rowe Price Mid Cap Growth Portfolio
Brighthouse Funds Trust I ·114 declared positions · as of Mar 31, 2026
Original filing · Net assets 1.1B $ · Ten largest lines: 20.4 % of the equity sleeve
Sector breakdown
- Consumer discretionary 14.0 %
- Technology 13.1 %
- Health care 10.7 %
- Industrials 10.4 %
- Financials 4.2 %
- Energy 3.9 %
- Materials 2.7 %
- Consumer staples 0.8 %
- Communication 0.3 %
- Unattributed 39.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 92.1 %
- BM 2.0 %
- GB 1.8 %
- DK 0.8 %
- CA 0.8 %
- JE 0.7 %
- CH 0.7 %
- NL 0.6 %
- DE 0.4 %
- KY 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 104 | 939.6M $ | 92.14 % |
| 2 | BM | 1 | 20.4M $ | 2.00 % |
| 3 | GB | 1 | 18M $ | 1.77 % |
| 4 | DK | 1 | 8.4M $ | 0.83 % |
| 5 | CA | 1 | 7.7M $ | 0.76 % |
| 6 | JE | 1 | 7.2M $ | 0.71 % |
| 7 | CH | 2 | 6.8M $ | 0.67 % |
| 8 | NL | 1 | 6.2M $ | 0.61 % |
| 9 | DE | 1 | 4.2M $ | 0.41 % |
| 10 | KY | 1 | 1M $ | 0.10 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Ralliant Corp | 58,163 | 2.4M $ | 0.23 % |
| 102 | CG oncology Inc | 34,435 | 2.3M $ | 0.22 % |
| 103 | CRISPR Therapeutics AG | 47,109 | 2.2M $ | 0.21 % |
| 104 | DraftKings Inc | 101,500 | 2.2M $ | 0.21 % |
| 105 | Caris Life Sciences Inc | 122,543 | 2.2M $ | 0.21 % |
| 106 | Unity Software Inc | 97,766 | 2.1M $ | 0.20 % |
| 107 | Kymera Therapeutics Inc | 24,000 | 2M $ | 0.19 % |
| 108 | Amphenol Corp | 15,800 | 2M $ | 0.19 % |
| 109 | Aurora Innovation Inc | 449,688 | 1.9M $ | 0.18 % |
| 110 | McGraw Hill Inc | 134,691 | 1.8M $ | 0.17 % |
| 111 | Revolution Medicines Inc | 16,500 | 1.6M $ | 0.15 % |
| 112 | QuidelOrtho Corp | 87,274 | 1.4M $ | 0.14 % |
| 113 | Nuvalent Inc | 10,372 | 1.1M $ | 0.10 % |
| 114 | Bullish | 29,028 | 1M $ | 0.10 % |